X
30Jun

Healthcare M&A prospers, despite fall in deal activity

The megadeals of 2019 may be off the table for now, but deal activity across healthcare and pharmaceuticals has proven resilient through the COVID-19 crisis - Although pharma, medical and biotech (PMB) M&A deal value for Q1 2020 came in at US$39.3 billion, 78% below the year before, this was primarily due to the outsized US$87.8 billion deal between Bristol-Myers Squibb and Celgene in early 2019....
By: White & Case LLP
Source Url: https://www.jdsupra.com/legalnews/healthcare-m-a-prospers-despite-fall-in-84295/

Related

Passage Of The SECURE Act At Last!

At long last, the Setting Every Community Up for Retirement Enhancement Act of 2019 (the SECURE Act)...

Read More >

FTC Revises Hart-Scott-Rodino Thresholds for 2020

On January 28, 2020, the Federal Trade Commission announced revised notification thresholds pursuant...

Read More >

What to Do When Your Business Receives a No-Match Letter

If your business is one of the 570,000 issued a No-Match Letter from the Social Security Administrat...

Read More >

U.S Senate Takes Aim at Big Tech

Hard on the heels of the muckle of anti-trust filings against the huge U.S. technology companies in ...

Read More >

HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums

In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a...

Read More >

New Legislation Precludes Employers in Puerto Rico from Using Credit Reports or Credit History to Take Employment Actions

On October 8, 2019, the Governor of Puerto Rico signed into law Act No. 150 of October 8, 2019 (“Ac...

Read More >